Genomics

Dataset Information

0

MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (miRNA-Seq)


ABSTRACT: CDK4/6 inhibition is now part of the standard armamentarium for patients with estrogen receptor (ER)-positive breast cancer, so that defining mechanisms of resistance is a pressing issue. Here, we identify increased CDK6 expression as a key determinant of acquired resistance after exposure to palbociclib in ER-positive breast cancer cells. Increased CDK6 in resistant cells was dependent on TGF-β pathway suppression via miR-432-5p expression. Exosomal miR-432-5p expression mediated transfer of the resistance phenotype between neighboring cell populations. We confirmed these data in pre-treatment and post-progression biopsies from a parotid cancer patient who had responded to ribociclib, demonstrating clinical relevance of this mechanism. Additionally, the CDK4/6 inhibitor resistance phenotype can be reversed in vitro and in vivo by a prolonged drug holiday.

ORGANISM(S): Homo sapiens

PROVIDER: GSE117747 | GEO | 2019/03/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-03-04 | GSE117746 | GEO
2019-03-04 | GSE117745 | GEO
2019-03-04 | GSE117743 | GEO
2019-03-04 | GSE117742 | GEO
2022-08-05 | GSE210399 | GEO
2022-02-16 | PXD023137 | Pride
2017-02-08 | GSE74391 | GEO
2021-01-06 | GSE164311 | GEO
2016-01-07 | E-GEOD-76576 | biostudies-arrayexpress
2021-02-09 | GSE158724 | GEO